| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 140,264 | 135,725 | 140,773 | 152,644 | | Cost of Revenue | 53,686 | 55,614 | 56,021 | 79,708 | | | Gross Profit | 86,578 | 80,111 | 84,752 | 72,936 | | | Operating Expenses | | Research Development | 29,425 | 28,923 | 28,559 | 28,533 | | Selling General and Administrative | 60,553 | 68,476 | 73,939 | 81,779 | | Non Recurring | 877 | 175,583 | 794 | 198,823 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,277) | (192,871) | (18,540) | (236,199) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,893 | (551) | 2,175 | 1,361 | | Earnings Before Interest And Taxes | (3,581) | (192,767) | (17,020) | (223,107) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,581) | (192,767) | (17,020) | (223,107) | | Income Tax Expense | 686 | 1,210 | 1,549 | 17,392 | | Minority Interest | 5,787 | 12,081 |
-
| 12,426 | | | | Net Income From Continuing Ops | 1,520 | (181,896) | (18,569) | (240,499) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,520 | (181,896) | (18,569) | (240,499) | | Preferred Stock And Other Adjustments |
-
| (6,433) | 6,433 |
-
| | | Net Income Applicable To Common Shares | $1,520 | ($188,329) | ($12,136) | ($240,499) |
|
0.51% Nasdaq 
Income Statement
